Nomura Research Institute, Ltd. (FRA:NR7)
25.80
-4.80 (-15.69%)
At close: Jan 30, 2026
Nomura Research Institute Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 798,901 | 764,813 | 736,556 | 692,165 | 611,634 | 550,337 | |
Revenue Growth (YoY) | 5.85% | 3.84% | 6.41% | 13.17% | 11.14% | 4.06% |
Cost of Revenue | 505,122 | 489,517 | 475,549 | 452,336 | 395,562 | 364,539 |
Gross Profit | 293,779 | 275,296 | 261,007 | 239,829 | 216,072 | 185,798 |
Selling, General & Admin | 144,056 | 144,071 | 142,353 | 131,580 | 113,536 | 98,366 |
Other Operating Expenses | -712 | -2,604 | -283 | -1,331 | -123 | 4,526 |
Operating Expenses | 143,344 | 141,467 | 142,070 | 130,249 | 113,413 | 102,892 |
Operating Income | 150,435 | 133,829 | 118,937 | 109,580 | 102,659 | 82,906 |
Interest Expense | -4,775 | -5,684 | -6,095 | -4,807 | -1,382 | -1,005 |
Interest & Investment Income | 5,546 | 4,255 | 3,405 | 2,066 | 1,705 | 1,258 |
Earnings From Equity Investments | 901 | 902 | 780 | 450 | 204 | 62 |
Other Non Operating Income (Expenses) | -3 | 681 | -498 | -592 | -1,872 | -9,925 |
EBT Excluding Unusual Items | 152,104 | 133,983 | 116,529 | 106,697 | 101,314 | 73,296 |
Gain (Loss) on Sale of Investments | - | 15 | 1,430 | -438 | - | - |
Gain (Loss) on Sale of Assets | - | - | 15 | 2,239 | 3,356 | - |
Asset Writedown | - | 162 | -751 | - | - | -2,220 |
Pretax Income | 152,104 | 134,160 | 117,223 | 108,498 | 104,670 | 71,076 |
Income Tax Expense | 46,319 | 39,778 | 37,062 | 32,002 | 32,878 | 18,497 |
Earnings From Continuing Operations | 105,785 | 94,382 | 80,161 | 76,496 | 71,792 | 52,579 |
Minority Interest in Earnings | -617 | -620 | -518 | -189 | -347 | 288 |
Net Income | 105,168 | 93,762 | 79,643 | 76,307 | 71,445 | 52,867 |
Net Income to Common | 105,168 | 93,762 | 79,643 | 76,307 | 71,445 | 52,867 |
Net Income Growth | 16.41% | 17.73% | 4.37% | 6.80% | 35.14% | -23.69% |
Shares Outstanding (Basic) | 573 | 573 | 582 | 592 | 593 | 598 |
Shares Outstanding (Diluted) | 573 | 573 | 582 | 592 | 594 | 600 |
Shares Change (YoY) | -0.28% | -1.51% | -1.70% | -0.27% | -1.04% | -5.55% |
EPS (Basic) | 183.63 | 163.56 | 136.90 | 128.92 | 120.57 | 88.34 |
EPS (Diluted) | 183.63 | 163.56 | 136.84 | 128.88 | 120.34 | 88.12 |
EPS Growth | 16.73% | 19.53% | 6.18% | 7.10% | 36.56% | -19.20% |
Free Cash Flow | 137,904 | 123,536 | 134,793 | 106,838 | 91,313 | 76,960 |
Free Cash Flow Per Share | 240.78 | 215.50 | 231.59 | 180.45 | 153.80 | 128.28 |
Dividend Per Share | 69.000 | 63.000 | 53.000 | 45.000 | 40.000 | 36.000 |
Dividend Growth | 18.97% | 18.87% | 17.78% | 12.50% | 11.11% | 12.50% |
Gross Margin | 36.77% | 35.99% | 35.44% | 34.65% | 35.33% | 33.76% |
Operating Margin | 18.83% | 17.50% | 16.15% | 15.83% | 16.78% | 15.07% |
Profit Margin | 13.16% | 12.26% | 10.81% | 11.02% | 11.68% | 9.61% |
Free Cash Flow Margin | 17.26% | 16.15% | 18.30% | 15.43% | 14.93% | 13.98% |
EBITDA | 200,577 | 182,739 | 167,094 | 154,672 | 144,600 | 123,817 |
EBITDA Margin | 25.11% | 23.89% | 22.69% | 22.35% | 23.64% | 22.50% |
D&A For EBITDA | 50,142 | 48,910 | 48,157 | 45,092 | 41,941 | 40,911 |
EBIT | 150,435 | 133,829 | 118,937 | 109,580 | 102,659 | 82,906 |
EBIT Margin | 18.83% | 17.50% | 16.15% | 15.83% | 16.78% | 15.07% |
Effective Tax Rate | 30.45% | 29.65% | 31.62% | 29.49% | 31.41% | 26.02% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.